# Allo CART-19 Protocol

> **NCT01551043** · PHASE1 · TERMINATED · sponsor: **University of Pennsylvania** · enrollment: 2 (actual)

## Conditions studied

- Acute Lymphocytic Leukemia

## Interventions

- **BIOLOGICAL:** CART-19

## Key facts

- **NCT ID:** NCT01551043
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-09
- **Primary completion:** 2015-05
- **Final completion:** 2016-06
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Administrative Reasons
- **Last updated:** 2020-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01551043

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01551043, "Allo CART-19 Protocol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01551043. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*